Triple-negative breast cancer trials in Sweden

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

  Where

  Boras, Lund, Solna, Uppsala

  Age

  18 years and over

  People

  2,400 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06966700 · EU 2024-520190-12-00
• Phase 3Taking people
  Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

  Where

  Boras, Gavle, Goteborg, Solna, Stockholm, Uppsala

  Age

  18 years and over

  People

  1,530 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06393374 · EU 2023-504962-52-00
• Phase 2/3Taking people
  A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

  Where

  Linkoping, Malmo, Orebro, Stockholm, Uppsala

  Age

  18 years and over

  People

  600 worldwide

  Run by

  Bristol-Myers Squibb

  See details and how to joinNCT06926868 · EU 2024-519871-24-00
• No phaseTaking people
  Use of Imatinib to Convert Triple Negative Breast Cancer Into ER-positive Breast Cancer (I-CONIC)

  Where

  Gothenburg

  Age

  18 years and over

  People

  40

  Run by

  Vastra Gotaland Region

  See details and how to joinNCT05722795